Literature DB >> 9282964

High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea.

H M Malaty1, J G Kim, H M El-Zimaity, D Y Graham.   

Abstract

BACKGROUND: Although gastric cancer and duodenal ulcer are both related to Helicobacter pylori infection, they are mutually exclusive diseases such that patients with a history of duodenal ulcer have a markedly reduced risk of developing gastric cancer. It has been hypothesized that different strains of H. pylori may be related to the different diseases. Our aim was to study the prevalence of duodenal ulcer disease and gastric cancer in dyspeptic patients in South Korea, a country with a high incidence of gastric cancer.
METHODS: The study population consisted of consecutive patients between the ages of 20 and 81 years referred to Guro Hospital's Endoscopic Unit for evaluation of dyspepsia. Patients with a history of peptic ulcer or gastric cancer were excluded. Each patient underwent endoscopy and completed a detailed questionnaire. Peptic ulcer was defined as the presence of an active ulcer, red scar, or white scar.
RESULTS: One thousand patients were evaluated, and 867 (43% men and 57% women) met the entry criteria. The prevalence of peptic ulcer and gastric cancer were 24% and 7%, respectively. Among peptic ulcer patients, duodenal ulcer was commoner (75%) than gastric ulcer or coexistent duodenal and gastric ulcer (21% and 4%, respectively). The mean age of duodenal and gastric ulcer patients (45 +/- 14 and 48 +/- 12 years, respectively) was significantly lower than that of gastric cancer patients (59 +/- 11 years) (P < 0.01). Only 44 (7%) of the 597 remaining patients had definite endoscopic abnormalities (for example, erosive esophagitis, duodenitis, or pyloric deformity).
CONCLUSION: Gastric cancer and duodenal ulcer were prevalent diagnoses among Korean patients undergoing endoscopy for evaluation of dyspepsia. Korea may be the ideal country to investigate the relation between specific H. pylori strains and different H. pylori diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9282964     DOI: 10.3109/00365529708996529

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  H pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response.

Authors:  David A Bland; Giovanni Suarez; Ellen J Beswick; Johanna C Sierra; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  H. pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response.

Authors:  David A Bland; Giovanni Suarez; Ellen J Beswick; Johanna C Sierra; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

Review 3.  Gastric atrophy, diagnosing and staging.

Authors:  Hala M T El-Zimaity
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 4.  History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer.

Authors:  David Y Graham
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 5.  Different Pathophysiology of Gastritis between East and West? An Asian Perspective.

Authors:  Hidekazu Suzuki; Hideki Mori
Journal:  Inflamm Intest Dis       Date:  2016-05-20

6.  The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea.

Authors:  Woon Geon Shin; Ha Jung Kim; Sung Jin Cho; Hyoung Su Kim; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Hak Yang Kim
Journal:  Gut Liver       Date:  2012-05-22       Impact factor: 4.519

7.  Comparison of the 13C-urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading.

Authors:  Young-Seok Cho; Hiun-Suk Chae; Se Na Jang; Jin-Soo Kim; Hye Suk Son; Hyung-Keun Kim; Byung-Wook Kim; Sok-Won Han; Kyu-Yong Choi; Hae Kyung Lee; Eun Deok Chang
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.